Fusion Pharmaceuticals Inc. (NASDAQ:FUSN – Get Free Report)’s stock price hit a new 52-week high during trading on Monday . The stock traded as high as $21.32 and last traded at $21.29, with a volume of 225039 shares trading hands. The stock had previously closed at $21.24. Analyst Ratings Changes Several analysts have commented on […]
Fusion Pharmaceuticals Inc. (NASDAQ:FUSN – Free Report) – Investment analysts at Wedbush decreased their Q1 2024 EPS estimates for Fusion Pharmaceuticals in a research note issued to investors on Wednesday, March 20th. Wedbush analyst D. Nierengarten now forecasts that the company will earn ($0.34) per share for the quarter, down from their prior estimate of […]
Royal Bank of Canada Reiterates "Sector Perform" Rating for Fusion Pharmaceuticals (NASDAQ:FUSN) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Royal Bank of Canada reiterated their sector perform rating on shares of Fusion Pharmaceuticals (NASDAQ:FUSN – Free Report) in a report issued on Wednesday morning, Benzinga reports. The brokerage currently has a $21.00 price objective on the stock, up from their previous price objective of $16.00. FUSN has been the topic of several other research […]
William Blair cut shares of Fusion Pharmaceuticals (NASDAQ:FUSN – Free Report) from an outperform rating to a market perform rating in a report published on Tuesday, MarketBeat.com reports. William Blair also issued estimates for Fusion Pharmaceuticals’ Q1 2025 earnings at ($0.45) EPS, Q2 2025 earnings at ($0.46) EPS, Q3 2025 earnings at ($0.47) EPS and […]